Heart failure patients who suffered prior myocardial infarction and anterior scarring saw no improvements in clinical outcomes when treated with the Revivent TC anchor system verses guideline-directed medical therapy (GDMT) alone in the ALIVE trial, despite reductions in left ventricular (LV) dimensions.